Effects_NNS of_IN Neutrophils_NNS on_IN Cefazolin_NP Activity_NP and_CC Penicillin-Binding_NP Proteins_NPS in_IN Staphylococcus_NP aureus_NN Abscesses_NP Bacteria_NP survive_VB within_IN abscesses_NNS despite_IN antimicrobial_JJ therapy_NN ,_, usually_RB necessitating_VBG drainage_NN ._SENT Our_PP$ previous_JJ work_NN showed_VBD that_IN bacterial_JJ killing_NN is_VBZ diminished_VBN within_IN the_DT neutrophils_NNS of_IN animals_NNS with_IN abscesses_NNS ._SENT To_TO further_RBR assess_VB the_DT role_NN of_IN neutrophils_NNS in_IN Staphylococcus_NP aureus_NN survival_NN and_CC the_DT poor_JJ activities_NNS of_IN beta-lactams_NNS in_IN abscesses_NNS ,_, tissue_NN cage_NN abscess-bearing_NN rats_NNS were_VBD given_VBN polymorphonuclear_JJ leukocyte_NN (PMN)-depleting_NN antibody_NN prior_RB to_TO and_CC several_JJ times_NNS following_VBG inoculation_NN of_IN the_DT tissue_NN cages_VBZ with_IN S._NP aureus_NN ._SENT Cefazolin_NP (_( 300_CD mg/kg_NN of_IN body_NN weight/day_NN )_) was_VBD administered_VBN to_TO all_DT animals_NNS in_IN appropriately_RB divided_VBN doses_NNS ._SENT After_IN 7_CD days_NNS of_IN antimicrobial_JJ therapy_NN ,_, the_DT 17_CD animals_NNS that_WDT received_VBD anti-PMN_JJ serum_NN had_VBD significantly_RB fewer_JJR abscess_NN neutrophils_NNS than_IN the_DT 18_CD controls_NNS and_CC fewer_JJR abscess_NN bacteria_NNS (_( 5.55_CD versus_IN 3.79_CD log10_NP CFU/ml_NP [_SYM P_NN =_SYM 0.04_CD ]_SYM )_) than_IN the_DT 18_CD controls_NNS ._SENT The_DT data_NNS were_VBD consistent_JJ with_IN the_DT premise_NN that_IN cefazolin_NN is_VBZ more_RBR effective_JJ in_IN abscesses_NNS depleted_VBN of_IN neutrophils_NNS ._SENT To_TO investigate_VB further_RBR ,_, S._NP aureus_NN was_VBD incubated_VBN with_IN rat_NN peritoneal_JJ neutrophils_NNS ;_: and_CC bacterial_JJ cell_NN membrane_NN proteins_NNS were_VBD isolated_VBN ,_, labeled_VBN with_IN biotinylated_JJ ampicillin_NN ,_, separated_VBN by_IN electrophoresis_NN ,_, blotted_VBN onto_IN nitrocellulose_NN ,_, and_CC stained_VBD for_IN biotin_NN reactivity_NN ._SENT PBP_NP 2_CD expression_NN was_VBD consistently_RB and_CC significantly_RB decreased_VBN after_IN a_DT brief_NN ,_, nonkilling_VBG PMN_JJ exposure_NN ._SENT These_DT experiments_NNS showed_VBD that_IN PMN_JJ depletion_NN enhanced_VBD the_DT activity_NN of_IN cefazolin_NN in_IN the_DT abscess_NN milieu_NN ._SENT Furthermore_RB ,_, altered_JJ bacterial_JJ cell_NN wall_NN cefazolin_NN targets_NNS may_MD be_VB the_DT mechanism_NN by_IN which_WDT the_DT PMN_NN diminishes_VBZ antimicrobial_JJ activity_NN ,_, suggesting_VBG the_DT importance_NN of_IN the_DT staphylococcus-PMN_JJ interaction_NN in_IN the_DT outcome_NN of_IN established_JJ infections_NNS ._SENT The_DT rapid_JJ delivery_NN of_IN neutrophils_NNS over_IN the_DT first_JJ 4_CD to_TO 6_CD h_NN to_TO a_DT site_NN of_IN infection_NN is_VBZ known_VBN to_TO play_VB an_DT important_JJ role_NN in_IN controlling_VBG an_DT acute_JJ infection_NN ._SENT Once_RB the_DT infection_NN is_VBZ established_VBN ,_, however_RB ,_, the_DT activities_NNS of_IN antimicrobials_NNS in_IN a_DT suppurative_JJ environment_NN are_VBP limited_VBN ._SENT Most_JJS abscesses_NNS require_VBP surgical_JJ drainage_NN for_IN cure_NN ._SENT However_RB ,_, some_DT abscesses_NNS respond_VBP to_TO antimicrobial_JJ therapy_NN without_IN drainage_NN ,_, and_CC the_DT mechanisms_NNS by_IN which_WDT antimicrobial_JJ activity_NN is_VBZ diminished_VBN in_IN a_DT suppurative_JJ environment_NN are_VBP only_RB partially_RB understood_VBN ._SENT Although_IN the_DT diminished_JJ growth_NN rate_NN of_IN bacteria_NNS in_IN abscesses_NNS is_VBZ likely_RB important_JJ in_IN affecting_VBG the_DT reduced_VBN effectiveness_NN of_IN antimicrobials_NNS in_IN a_DT suppurative_JJ environment_NN ,_, we_PP had_VBD previously_RB been_VBN unable_JJ to_TO correlate_VB antimicrobial_JJ activity_NN in_IN an_DT abscess_NN with_IN the_DT antimicrobial_JJ activity_NN against_IN stationary-phase_NN organisms_NNS ._SENT We_PP found_VBD that_IN beta-lactam_NN antimicrobials_NNS had_VBD only_RB marginal_JJ efficacies_NNS ,_, despite_IN adequate_JJ antimicrobial_JJ concentrations_NNS ,_, and_CC that_IN the_DT activities_NNS of_IN antimicrobials_NNS in_IN polymorphonuclear_JJ leukocytes_NNS (_( PMNs_NP )_) correlated_VBD with_IN in_IN vivo_JJ efficacy_NN ._SENT The_DT PMN_NN may_MD act_VB as_IN a_DT sanctuary_NN since_IN we_PP have_VBP previously_RB found_VBN that_IN killing_VBG by_IN PMNs_NP ,_, but_CC not_RB phagocytosis_NN of_IN staphylococci_NNS ,_, (_( i_NP )_) is_VBZ inhibited_VBN systemically_RB by_IN the_DT presence_NN of_IN an_DT abscess_NN and_CC (_( ii_NN )_) may_MD be_VB further_RBR inhibited_VBN in_IN the_DT abscess_NN milieu_NN ._SENT In_IN this_DT study_NN ,_, we_PP sought_VBD to_TO directly_RB determine_VB the_DT role_NN of_IN the_DT PMNs_NP in_IN diminishing_VBG the_DT activities_NNS of_IN beta-lactams_NNS in_IN an_DT abscess_NN ._SENT We_PP postulated_VBD that_IN neutrophils_NNS ,_, although_IN important_JJ in_IN the_DT immediate_JJ control_NN of_IN pyogenic_JJ infections_NNS ,_, may_MD inhibit_VB the_DT activities_NNS of_IN beta-lactams_NNS in_IN an_DT established_VBN abscess_NN and_CC that_IN a_DT reduction_NN in_IN the_DT rate_NN of_IN PMN_JJ influx_NN into_IN an_DT abscess_NN could_MD enhance_VB the_DT killing_VBG effects_NNS of_IN beta-lactams_NNS ._SENT Previous_JJ studies_NNS have_VBP provided_VBN some_DT evidence_NN to_TO support_VB this_DT hypothesis_NN ,_, but_CC the_DT question_NN either_CC was_VBD not_RB studied_VBN directly_RB or_CC conflicting_JJ results_NNS were_VBD presented_VBN ._SENT Gerding_NP et_FW al._FW showed_VBD improved_VBN killing_VBG of_IN Staphylococcus_NP aureus_NN by_IN cephalothin_NN in_IN a_DT subcutaneously_RB implanted_VBN cellulose_NN tubing_NN chamber_NN which_WDT excluded_VBD cells_NNS or_CC molecules_NNS >15_NN kDa_NN compared_VBN to_TO the_DT killing_NN by_IN cephalothin_NN in_IN a_DT tissue_NN cage_NN abscess_NN in_IN the_DT presence_NN of_IN neutrophils_NNS ._SENT However_RB ,_, the_DT differences_NNS in_IN anatomy_NN and_CC blood_NN supply_NN in_IN the_DT control_NN and_CC test_NN models_NNS made_VBD the_DT precise_JJ role_NN of_IN the_DT PMNs_NP less_RBR well_RB defined_VBN ._SENT Calame_NP et_FW al._FW evaluated_VBN the_DT effects_NNS of_IN granulocytes_NNS on_IN the_DT clearance_NN of_IN S._NP aureus_NN by_IN cloxacillin_NN over_IN 4_CD h._NN They_PP found_VBD that_IN when_WRB small_JJ doses_NNS of_IN cloxacillin_NN were_VBD used_VBN ,_, bacterial_JJ clearance_NN was_VBD diminished_VBN by_IN PMN_JJ depletion_NN ,_, but_CC when_WRB the_DT largest_JJS dose_NN was_VBD used_VBN ,_, the_DT antimicrobial_JJ activity_NN was_VBD enhanced_VBN by_IN the_DT depletion_NN of_IN neutrophils_NNS (_( although_IN statistical_JJ significance_NN was_VBD not_RB provided_VBN )_) ._SENT It_PP is_VBZ known_VBN that_IN neutrophils_NNS diminish_VBP the_DT penicillin-binding_NN protein_NN (_( PBP_NP )_) expression_NN of_IN Escherichia_NP coli_NNS ._SENT S._NP aureus_NN has_VBZ been_VBN shown_VBN to_TO have_VB altered_VBN gene_NN expression_NN on_IN internalization_NN by_IN endothelial_JJ cells_NNS ._SENT We_PP postulated_VBD that_IN if_IN neutrophils_NNS inhibit_VBP the_DT activities_NNS of_IN beta-lactams_NNS against_IN S._NP aureus_NN ,_, the_DT inhibition_NN might_MD also_RB be_VB through_IN a_DT mechanism_NN by_IN which_WDT bacteria_NNS are_VBP phagocytized_VBN but_CC not_RB killed_VBN ,_, with_IN subsequent_JJ alteration_NN in_IN the_DT expression_NN of_IN PBPs_NNS that_WDT are_VBP essential_JJ targets_NNS for_IN beta-lactam_NN activity_NN ._SENT To_TO test_VB our_PP$ postulates_NNS ,_, we_PP established_VBD a_DT novel_NN in_IN vivo_JJ neutropenic_JJ model_NN of_IN infection_NN ;_: the_DT animal_JJ model_NN used_VBN is_VBZ large_JJ enough_RB to_TO allow_VB repeated_JJ sampling_NN of_IN an_DT ongoing_JJ infection_NN ,_, yet_CC it_PP is_VBZ small_JJ enough_RB to_TO deplete_VB circulating_VBG neutrophils_NNS by_IN systemic_JJ treatment_NN rather_RB than_IN exclusion_NN from_IN a_DT particular_JJ site_NN ._SENT This_DT report_NN details_VBZ the_DT quantitative_JJ differences_NNS in_IN the_DT infective_JJ organism_NN ,_, the_DT differences_NNS in_IN the_DT host_NN cell_NN profile_NN ,_, and_CC the_DT differences_NNS in_IN antimicrobial_JJ activity_NN between_IN healthy_JJ and_CC neutropenic_JJ rats_NNS with_IN established_JJ infections_NNS and_CC offers_NNS suggestions_NNS ,_, based_VBN on_IN additional_JJ experiments_NNS ,_, on_IN the_DT mechanisms_NNS of_IN the_DT differences_NNS ._SENT Abscess_NN model_NN ._SENT |_SYM Thirty-five_JJ male_JJ rats_NNS (_( weight_NN ,_, >400_JJ g_NN )_) were_VBD anesthetized_VBN ,_, and_CC a_DT single_JJ table-tennis_NN ball_NN with_IN 300_CD 1.5-mm-diameter_NN holes_NNS was_VBD implanted_VBN in_IN the_DT peritoneal_JJ cavity_NN by_IN sterile_JJ techniques_NNS ._SENT Six_CD weeks_NNS after_IN implantation_NN ,_, 17_CD rats_NNS were_VBD given_VBN 0.75_CD ml_NN of_IN anti-PMN_JJ serum_NN of_IN rabbit_NN origin_NN (_( Accurate_NP Chemical_NP Corp._NP ,_, Westbury_NP ,_, N.Y._NP )_) mixed_JJ with_IN 1.25_CD ml_NN of_IN sterile_JJ saline_NN 1_CD day_NN before_IN infection_NN and_CC on_IN days_NNS 2_CD ,_, 4_CD ,_, and_CC 6_CD after_IN infection_NN ._SENT Preliminary_JJ experiments_NNS showed_VBD that_DT administration_NN of_IN anti-PMN_JJ serum_NN at_IN these_DT times_NNS was_VBD most_RBS effective_JJ at_IN depleting_VBG peripheral_JJ blood_NN neutrophil_NN counts_NNS ._SENT Eighteen_CD animals_NNS served_VBN as_IN controls_NNS and_CC received_VBN control_NN rabbit_NN serum_NN in_IN saline_NN ._SENT One_CD day_NN after_IN administration_NN of_IN the_DT initial_JJ dose_NN of_IN anti-PMN_JJ serum_NN ,_, the_DT capsules_NNS in_IN all_DT 35_CD rats_NNS were_VBD inoculated_VBN with_IN 5_CD x_SYM 107_CD CFU_NP of_IN an_DT S._NP aureus_NN isolate_NN initially_RB isolated_VBN from_IN a_DT bacteremic_JJ patient_NN ._SENT The_DT MIC_NN of_IN cefazolin_NN for_IN the_DT organism_NN is_VBZ 0.5_CD mug/ml_NN ,_, and_CC the_DT minimal_JJ bactericidal_JJ concentration_NN is_VBZ 1.0_CD mug/ml_NN ._SENT One_CD day_NN after_IN bacterial_JJ inoculation_NN ,_, all_DT animals_NNS were_VBD given_VBN cefazolin_NN at_IN 300_CD mg/kg_NN of_IN body_NN weight/day_NN (_( with_IN one-third_NN of_IN the_DT dose_NN given_VBN at_IN 8_CD a.m._NN and_CC two-thirds_NNS of_IN the_DT dose_NN given_VBN at_IN 5_CD p.m._NN )_) for_IN 7_CD days_NNS ._SENT The_DT capsules_NNS were_VBD sampled_VBN for_IN determination_NN of_IN bacterial_JJ and_CC PMN_JJ counts_NNS immediately_RB before_IN administration_NN of_IN the_DT 8_CD a.m._NN dose_NN on_IN days_NNS 2_CD ,_, 4_CD ,_, and_CC 7_CD after_IN the_DT initiation_NN of_IN antimicrobial_JJ therapy_NN ._SENT Abscess_NN fluid_NN was_VBD subjected_VBN to_TO sonication_NN at_IN 90_CD W_NN (_( model_NN 300_CD Sonic_NP Dismembrator_NP ;_: Fisher_NP ,_, Springfield_NP ,_, N.J._NP )_) for_IN 15_CD s_NN to_TO liberate_VB phagocytized_JJ S._NP aureus_NN ._SENT Aliquots_NNS were_VBD serially_RB diluted_JJ (_( 10-fold_NN )_) ,_, plated_VBN onto_IN blood_NN agar_NN plates_NNS ,_, and_CC incubated_VBD for_IN 24_CD h._NN The_DT lower_JJR limit_NN of_IN detection_NN was_VBD 10_CD CFU/ml_NN ._SENT Neutrophils_NNS were_VBD quantified_VBN by_IN determination_NN of_IN total_JJ cell_NN counts_NNS in_IN fresh_JJ abscess_NN fluid_NN with_IN a_DT hemocytometer_NNS ,_, followed_VBN by_IN determination_NN of_IN differential_JJ counts_NNS of_IN stained_VBN cytospin_NN preparations_NNS of_IN abscess_NN fluid_JJ to_TO determine_VB percent_NN neutrophils_NNS ._SENT Peripheral_JJ blood_NN PMN_NN counts_VBZ for_IN all_DT animals_NNS were_VBD determined_VBN on_IN the_DT same_JJ days_NNS that_IN the_DT capsules_NNS were_VBD sampled_VBN ._SENT Serum_NN for_IN counts_NNS and_CC assay_NN was_VBD obtained_VBN by_IN collecting_VBG blood_NN from_IN the_DT tail_JJ tip_NN and_CC placing_VBG it_PP in_IN pediatric_JJ serum_NN separator_NN tubes_NNS (_( Microtainer_NP ;_: Becton_NP Dickinson_NP Biosciences_NP ,_, Franklin_NP Lakes_NP ,_, N.J._NP )_) ._SENT Antibiotic_JJ assay_NN ._SENT |_SYM The_DT cefazolin_NN concentration_NN was_VBD measured_VBN by_IN an_DT agar_NN disk_NN diffusion_NN bioassay_NN with_IN Bacillus_NN subtilis_NNS ATCC_NP 66333_CD as_IN the_DT test_NN organism_NN ._SENT For_IN preparation_NN of_IN a_DT five-point_JJ standard_JJ curve_NN ,_, known_VBN quantities_NNS of_IN cefazolin_NN standard_NN in_IN control_NN rat_NN serum_NN were_VBD prepared_VBN in_IN plates_NNS with_IN antibiotic_JJ agar_NN 5_CD and_CC B._NP subtilis_NNS that_WDT were_VBD run_VBN simultaneously_RB with_IN 20-mul_JJ samples_NNS of_IN sterile-filtered_JJ abscess_NN fluid_NN (_( or_CC serum_NN )_) ._SENT The_DT samples_NNS with_IN the_DT cefazolin_NN standard_NN were_VBD then_RB added_VBN to_TO 6.3-mm_JJ filter_NN paper_NN discs_NNS ,_, and_CC the_DT discs_NNS were_VBD incubated_VBN for_IN 24_CD h._NNS The_DT diameter_NN of_IN the_DT clear_JJ zone_NN surrounding_VBG the_DT disk_NN was_VBD used_VBN to_TO prepare_VB a_DT standard_JJ curve_NN and_CC obtain_VB the_DT numbers_NNS of_IN micrograms_NNS of_IN cefazolin_NN per_IN milliliter_NN ._SENT Rat_NN PMN_NN isolation_NN ._SENT |_SYM A_DT sterile_JJ 1-mg/ml_JJ solution_NN of_IN oyster_NN shell_NN glycogen_NN (_( Sigma_NP Chemical_NP ,_, St._NP Louis_NP ,_, Mo._NP )_) in_IN saline_NN was_VBD administered_VBN into_IN the_DT peritoneum_NN of_IN an_DT anesthetized_VBN rat_NN at_IN a_DT dose_NN of_IN 4_CD ml/100_NN g_NN of_IN body_NN weight_NN through_IN an_DT 18-gauge_JJ tubing-tipped_JJ needle_NN ._SENT Four_CD hours_NNS later_RBR (_( while_IN the_DT rats_NNS were_VBD under_IN terminal_NN anesthesia_NN )_) ,_, 5_CD ml_NN of_IN sterile_JJ phosphate-buffered_JJ saline/100_NN g_NN was_VBD administered_VBN into_IN the_DT peritoneum_NN ,_, and_CC the_DT fluid_NN was_VBD drained_VBN to_TO yield_VB >108_JJ neutrophils_NNS uncontaminated_JJ with_IN erythrocytes_NNS ._SENT The_DT cells_NNS were_VBD washed_VBN two_CD times_NNS in_IN Hank_NP 's_POS balanced_JJ salt_NN solution_NN (_( HBSS_NP ;_: Sigma_NP )_) without_IN divalent_JJ cations_NNS and_CC were_VBD counted_VBN by_IN use_NN of_IN trypan_JJ blue_NN staining_VBG to_TO determine_VB viability_NN ._SENT Peripheral_JJ blood_NN neutrophils_NNS harvested_VBN from_IN the_DT total_JJ blood_NN volume_NN of_IN a_DT single_JJ rat_NN have_VBP occasionally_RB been_VBN used_VBN for_IN incubation_NN of_IN S._NP aureus_NN with_IN no_DT significant_JJ difference_NN in_IN effect_NN ._SENT These_DT are_VBP isolated_VBN by_IN standard_JJ procedures_NNS that_WDT include_VBP removal_NN of_IN monocytes_NNS by_IN centrifugation_NN of_IN blood_NN layered_VBN over_IN Hypaque_NP and_CC lysis_NN of_IN erythrocytes_NNS with_IN hypotonic_JJ ammonium_NN chloride_NN before_IN a_DT wash_NN with_IN HBSS_NP ._SENT Incubation_NN of_IN PMNs-bacteria_NP in_IN vitro_NP ._SENT |_SYM Five_NP hundred_CD milliliters_NNS of_IN antibiotic_JJ medium_NN 3_CD was_VBD spiked_VBN with_IN an_DT overnight_JJ growth_NN of_IN S._NP aureus_NN ,_, and_CC the_DT bacteria_NNS were_VBD allowed_VBN to_TO grow_VB for_IN 6_CD h_NN until_IN the_DT count_NN was_VBD about_RB 2_CD x_SYM 106_CD CFU/ml_NP ._SENT Following_VBG centrifugation_NN and_CC a_DT saline_JJ wash_NN ,_, half_PDT the_DT bacteria_NNS (_( approximately_RB 5_CD x_NN 108_CD )_) were_VBD suspended_VBN in_IN HBSS_NP with_IN opsonizing_VBG rat_NN serum_NN and_CC cations_NNS ,_, and_CC the_DT suspension_NN was_VBD incubated_VBN with_IN rat_NN peritoneal_JJ neutrophils_NNS (_( ratio_NN of_IN bacteria_NNS to_TO neutrophils_NNS ,_, 100:1_CD )_) for_IN 30_CD min_NN at_IN 37C_JJ in_IN a_DT water_NN bath_NN with_IN slow_JJ shaking_VBG ._SENT The_DT control_NN bacteria_NNS (_( which_WDT were_VBD not_RB incubated_VBN with_IN PMNs_NP but_CC to_TO which_WDT HBSS_NP was_VBD added_VBN to_TO form_VB a_DT volume_NN equal_JJ to_TO that_DT of_IN the_DT test_NN suspension_NN )_) were_VBD incubated_VBN for_IN 30_CD min_NN at_IN 37C_JJ in_IN the_DT same_JJ water_NN bath_NN ._SENT No_DT lysis_NN or_CC wash_VB to_TO separate_VB intracellular_JJ bacteria_NNS from_IN extracellular_JJ bacteria_NNS was_VBD performed_VBN ._SENT Phagocytosis_NN was_VBD evaluated_VBN in_IN pilot_NN experiments_NNS ._SENT At_IN 15_CD min_NN ,_, stained_VBD cytospin_NN preparations_NNS showed_VBD about_RB 20_CD neutrophils_NNS per_IN high-power_NN field_NN ,_, or_CC about_RB 1.3_CD x_SYM 104_CD neutrophils/mul_NN ._SENT About_IN one-third_NN of_IN these_DT contained_VBN about_IN 50_CD bacteria_NNS each_DT ,_, which_WDT is_VBZ considered_VBN to_TO be_VB very_RB good_JJ phagocytosis_NN ._SENT The_DT general_JJ characteristics_NNS of_IN the_DT preparations_NNS showed_VBD that_IN they_PP resembled_VBD cytospin_NN preparations_NNS of_IN in_IN vivo_JJ abscess_NN fluid_NN very_RB early_RB in_IN infection_NN ._SENT By_IN use_NN of_IN bacteria_NNS and_CC neutrophils_NNS at_IN a_DT 100:1_CD ratio_NN in_IN the_DT in_IN vitro_NN incubation_NN ,_, it_PP was_VBD determined_VBN on_IN the_DT basis_NN of_IN the_DT results_NNS of_IN pilot_NN experiments_NNS that_IN a_DT large_JJ number_NN of_IN the_DT S._NP aureus_NN organisms_NNS were_VBD internalized_VBN ._SENT Aliquots_NNS of_IN both_DT control_NN bacteria_NNS incubated_VBN without_IN PMNs_NNS and_CC bacteria_NNS incubated_VBN with_IN PMNs_NP were_VBD serially_RB diluted_VBN in_IN ice_NN water_NN and_CC plated_VBD to_TO determine_VB viability_NN ._SENT Methods_NNS for_IN PBP_NP isolation_NN ._SENT |_SYM The_DT S._NP aureus_NN organisms_NNS were_VBD resuspended_VBN in_IN 1_CD ml_NN of_IN phosphate_NN buffer_NN and_CC were_VBD homogenized_VBN in_IN a_DT 5-ml_JJ steel_NN blender_NN cup_NN on_IN ice_NN with_IN micro-glass_NN beads_NNS (_( two_CD times_NNS for_IN 5_CD min_NN each_DT time_NN )_) ._SENT The_DT cell_NN wall_NN proteins_NNS were_VBD isolated_VBN by_IN harvesting_VBG the_DT supernatants_NNS obtained_VBN by_IN centrifugation_NN at_IN 500_CD and_CC 5,000_CD x_SYM g_NN and_CC the_DT pellet_NN obtained_VBN by_IN centrifugation_NN at_IN 100,000_CD x_NN g_NN on_IN an_DT Optima_NP LE-80K_NP preparative_JJ ultracentrifuge_NN (_( Beckman-Coulter_NP ,_, Fullerton_NP ,_, Calif._NP )_) with_IN a_DT 70.1_CD Ti_NP rotor_NN at_IN 4C_JJ for_IN 30_CD min_NN ._SENT The_DT pellets_NNS were_VBD each_DT resuspended_JJ in_IN 0.05_CD ml_NN of_IN phosphate_NN buffer_NN ._SENT A_DT microassay_NN of_IN the_DT protein_NN in_IN this_DT suspension_NN (_( Bradford_NP assay_NN ;_: Bio-Rad_NP Laboratories_NPS ,_, Hercules_NP ,_, Calif._NP )_) showed_VBD that_IN 12_CD to_TO 13_CD mug_NN of_IN protein_NN was_VBD usually_RB recovered_VBN ._SENT The_DT membrane_NN pellets_NNS were_VBD incubated_VBN with_IN biotinylated_JJ ampicillin_NN (_( 30_CD min_NN at_IN 30C_JJ )_) and_CC recovered_VBD from_IN a_DT phosphate_NN buffer_NN wash_NN by_IN centrifugation_NN at_IN 100,000_CD x_SYM g._FW A_DT total_NN of_IN 0.05_CD ml_NN of_IN 2x_NP Laemmli_NP sample_NN buffer_NN was_VBD added_VBN to_TO the_DT resuspended_JJ pellets_NNS ,_, and_CC the_DT samples_NNS were_VBD boiled_VBN for_IN 2_CD min_NN and_CC separated_VBN on_IN sodium_NN dodecyl_NN sulfate-12_JJ %_NN polyacrylamide_NN gels_NNS next_JJ to_TO prestained_JJ molecular_JJ weight_NN markers_NNS ._SENT The_DT gels_NNS were_VBD blotted_VBN onto_IN nitrocellulose_NN overnight_RB ._SENT The_DT nitrocellulose_NN was_VBD blocked_VBN to_TO control_VB nonspecific_JJ staining_VBG and_CC was_VBD then_RB incubated_VBN with_IN avidin-alkaline_NN phosphatase_NN (_( Zymed_NP Labs_NP ,_, South_NP San_NP Francisco_NP ,_, Calif._NP )_) in_IN phosphate-buffered_JJ saline_NN (_( 1:1,000_CD )_) to_TO detect_VB the_DT protein_NN bands_NNS binding_VBG to_TO biotinylated_JJ ampicillin_NN ._SENT The_DT colorimetric_JJ substrate_NN for_IN alkaline_JJ phosphatase_NN was_VBD 5-bromo-4-chloro-3-indolylphosphate-nitroblue_JJ tetrazolium_NN (_( BCIP-NBT_NP ;_: Kirkegaard_NP &_CC Perry_NP Laboratories_NPS ,_, Gaithersburg_NP ,_, Md._NP )_) ._SENT Bands_NNS corresponding_JJ to_TO important_JJ S._NP aureus_NN PBPs_NNS were_VBD identified_VBN on_IN the_DT basis_NN of_IN a_DT standard_JJ curve_NN prepared_VBN on_IN each_DT blot_NN from_IN the_DT molecular_JJ weight_NN markers_NNS in_IN that_DT run_NN ._SENT The_DT blots_NNS were_VBD scanned_VBN into_IN a_DT density-quantifying_JJ program_NN (_( ImageQuaNT_NP ;_: Molecular_NP Dynamics_NPS ,_, Sunnyvale_NP ,_, Calif._NP )_) ,_, and_CC the_DT volume_NN and_CC density_NN of_IN each_DT PBP_NP band_NN were_VBD determined_VBN ._SENT Six_CD separate_JJ runs_NNS of_IN PBPs_NNS incubated_VBN with_IN PMNs_NNS and_CC control_NN PBPs_NNS were_VBD performed_VBN with_IN biotinylated_JJ ampicillin_NN as_IN the_DT beta-lactam_NN for_IN the_DT detection_NN of_IN PBPs_NP ._SENT Procedural_JJ controls_NNS ._SENT |_SYM It_PP was_VBD recognized_VBN that_IN endogenous_JJ S._NP aureus_NN protein_NN could_MD bind_VB to_TO streptavidin_NN and_CC thus_RB make_VB nonspecific_JJ bands_NNS ,_, so_RB procedural_JJ controls_NNS were_VBD run_VBN to_TO determine_VB the_DT degree_NN of_IN nonspecific_JJ background_NN staining_VBG ._SENT The_DT controls_NNS were_VBD prepared_VBN by_IN preincubation_NN with_IN (_( i_NP )_) cold_JJ ampicillin_NN before_IN the_DT addition_NN of_IN biotinylated_JJ ampicillin_NN ,_, (_( ii_NNS )_) no_DT ampicillin_NN but_CC the_DT biotin_NN linker_NN ,_, and_CC (_( iii_NNS )_) no_DT ampicillin_NN and_CC no_DT linker_NN ._SENT Two_CD other_JJ beta-lactam_NN labels_NNS that_WDT did_VBD not_RB use_VB biotin_NN recognition_NN were_VBD also_RB used_VBN as_IN procedural_JJ controls_NNS :_: digoxigenin-ampicillin_NN and_CC fluorescent_JJ penicillin_NN ._SENT Separate_JJ assays_NNS were_VBD also_RB performed_VBN with_IN washed_JJ neutrophils_NNS (_( instead_RB of_IN S._NP aureus_NN )_) to_TO determine_VB if_IN the_DT PMN_JJ protein_NN nonspecifically_RB bound_VBN to_TO the_DT beta-lactam_NN label_NN ._SENT Controls_NNS were_VBD scanned_VBN into_IN the_DT ImageQuaNT_NP program_NN ,_, and_CC the_DT densities_NNS of_IN the_DT peaks_NNS coinciding_VBG with_IN S._NP aureus_NN PBPs_NNS were_VBD determined_VBN ._SENT beta-Lactam_NN labels_NNS for_IN detection_NN of_IN PBPs_NP ._SENT (_( i_NP )_) Biotinylated_JJ ampicillin_NN ._SENT |_SYM The_DT biotinylation_NN method_NN of_IN Dargis_NP and_CC Malouin_NP was_VBD followed_VBN ,_, with_IN slight_JJ modification_NN ._SENT Ampicillin_NP was_VBD linked_VBN to_TO biotin-7-N-hydroxysuccinimide_NN ,_, which_WDT formed_VBD a_DT stable_JJ amide_NN bond_NN ,_, by_IN gentle_JJ rocking_VBG at_IN room_NN temperature_NN for_IN 2_CD h_NN in_IN a_DT dimethyl_NN sulfoxide-phosphate_NN buffer_NN solution_NN ._SENT Unreacted_JJ biotin_NN and_CC linker_NN were_VBD removed_VBN by_IN the_DT addition_NN of_IN Affigel_NP 102_CD (_( Bio-Rad_NP )_) in_IN excess_NN with_IN rocking_VBG overnight_JJ ._SENT Biotinylated_JJ ampicillin_NN was_VBD recovered_VBN by_IN centrifugation_NN and_CC was_VBD used_VBN only_RB on_IN that_DT day_NN ._SENT (_( ii_NP )_) Digoxigenin_NP ._SENT |_SYM An_DT amide_NN bond_NN between_IN ampicillin_NN and_CC digoxigenin-_NN N-hydroxysuccinimide_NN ester_NN (_( Roche_NP Diagnostics_NP ,_, Indianapolis_NP ,_, Ind._NP )_) was_VBD made_VBN by_IN the_DT methods_NNS recommended_VBN by_IN the_DT supplier_NN ._SENT After_IN cleanup_NN ,_, the_DT digoxigenin-ampicillin_NN was_VBD stored_VBN at_IN -70C_NN until_IN use_NN (_( within_IN 2_CD weeks_NNS )_) as_IN a_DT procedural_JJ control_NN ._SENT Detection_NN of_IN proteins_NNS that_IN bound_VBN to_TO digoxigenin-ampicillin_NN was_VBD done_VBN by_IN blot_NN incubation_NN with_IN anti-digoxigenin-alkaline_NN phosphatase_NN (_( 1:1,500_CD ;_: Roche_NP )_) in_IN 100_CD mM_NP Tris-saline_NP ._SENT BCIP-NBT_NN substrate_NN for_IN alkaline_JJ phosphatase_NN was_VBD used_VBN for_IN color_NN development_NN ._SENT (_( iii_NP )_) Fluorescent_JJ penicillin_NN ._SENT |_SYM By_IN using_VBG our_PP$ standard_JJ PBP_NP isolation_NN and_CC gel_NN separation_NN procedures_NNS ,_, fluorescent_JJ penicillin_NN (_( Bocillin_NP FL_NP ;_: Molecular_NP Probes_NP ,_, Eugene_NP ,_, Oreg_NP ._SENT )_) was_VBD used_VBN to_TO quantify_VB S._NP aureus_NN PBPs_NNS by_IN the_DT labeling_VBG procedures_NNS of_IN Zhao_NP et_FW al._FW ._SENT The_DT sodium_NN dodecyl_NN sulfate-polyacrylamide_NN gels_NNS were_VBD read_VBN on_IN a_DT STORM_NP Fluor-Imager_NP (_( Molecular_NP Dynamics_NP ,_, Sunnyvale_NP ,_, Calif._NP )_) and_CC analyzed_VBD with_IN the_DT ImageQuaNT_NP program_NN ._SENT Statistics_NNS ._SENT |_SYM Comparisons_NP of_IN bacterial_JJ and_CC PMN_JJ counts_NNS and_CC cefazolin_NN concentrations_NNS were_VBD performed_VBN with_IN data_NNS for_IN control_NN animals_NNS and_CC animals_NNS treated_VBN with_IN PMN-depleting_JJ antibody_NN by_IN Mann-Whitney_NP U_NP tests_NNS and_CC other_JJ nonparametric_JJ tests_NNS with_IN Statistica_NP software_NN ._SENT Bacterial_JJ and_CC PMN_JJ counts_NNS were_VBD log_NN transformed_VBN for_IN presentation_NN in_IN graphic_JJ form_NN ._SENT PBP_JJ binding_JJ data_NNS obtained_VBN by_IN using_VBG the_DT density_NN values_NNS generated_VBN with_IN the_DT ImageQuaNT_NP program_NN were_VBD analyzed_VBN by_IN two-tailed_JJ Student_NN 's_POS t_NN tests_NNS ._SENT P_NN values_NNS <0.05_NN were_VBD considered_VBN significant_JJ ._SENT Animal_JJ model_NN ._SENT |_SYM Six_CD weeks_NNS after_IN implantation_NN of_IN the_DT table-tennis_NN ball_NN in_IN large_JJ rats_NNS ,_, the_DT ball_NN became_VBD encased_VBN in_IN connective_JJ tissue_NN ,_, developed_VBD a_DT blood_NN supply_NN ,_, and_CC became_VBD filled_VBN with_IN a_DT sterile_JJ fluid_NN that_WDT had_VBD the_DT appearance_NN of_IN serum_NN ._SENT The_DT single_JJ capsule_NN ,_, which_WDT is_VBZ readily_RB tolerated_VBN by_IN larger_JJR rats_NNS ,_, allowed_VBD us_PP to_TO correlate_VB the_DT cell_NN numbers_NNS and_CC bacterial_JJ counts_NNS in_IN a_DT single_JJ abscess_NN with_IN the_DT peripheral_JJ cell_NN counts_NNS ,_, which_WDT is_VBZ not_RB possible_JJ with_IN the_DT three-capsule_NN rabbit_NN model_NN in_IN common_JJ use_NN ._SENT Circulating_VBG and_CC abscess_NN PMN_NN counts_NNS and_CC cefazolin_NN concentrations_NNS ._SENT |_SYM Use_NN of_IN anti-PMN_JJ serum_NN significantly_RB diminished_VBN both_CC the_DT circulating_VBG and_CC the_DT abscess_NN PMN_NN counts_VBZ in_IN rats_NNS infected_VBN with_IN S._NP aureus_NN during_IN the_DT entirety_NN of_IN the_DT 7_CD days_NNS of_IN treatment_NN with_IN cefazolin_NN (_( Fig._NN and_CC B_NN )_) ._SENT At_IN day_NN 7_CD the_DT median_NN circulating_VBG PMN_JJ counts_NNS were_VBD 9,549_CD and_CC 2,137_CD PMNs/ml_NN for_IN the_DT control_NN animals_NNS and_CC the_DT animals_NNS treated_VBN with_IN PMN-depleting_JJ antibody_NN ,_, respectively_RB (_( P_NN =_SYM 0.003_CD )_) ,_, while_IN the_DT median_JJ abscess_NN PMN_NN counts_NNS were_VBD 3,388_CD and_CC 436_CD PMNs/ml_NN ,_, respectively_RB (_( P_NN <_SYM 0.001_CD )_) ._SENT The_DT cefazolin_NN concentrations_NNS were_VBD similar_JJ in_IN the_DT abscess_NN fluids_NNS of_IN the_DT two_CD treatment_NN groups_NNS ._SENT The_DT abscess_NN fluid_NN of_IN the_DT controls_NNS had_VBD average_JJ cefazolin_NN concentrations_NNS of_IN 18.2_CD +-_NN 12.5_CD mug/ml_NN ,_, and_CC the_DT abscess_NN fluid_NN of_IN neutropenic_JJ rats_NNS had_VBD average_JJ cefazolin_NN concentrations_NNS of_IN 23.7_CD +-_NN 12.8_CD mug/ml_NN (_( P_NN =_SYM 0.19_CD )_) ._SENT S._NP aureus_NN counts_NNS in_IN abscesses_NNS ._SENT |_SYM By_IN days_NNS 2_CD and_CC 4_CD of_IN cefazolin_JJ therapy_NN there_EX was_VBD a_DT trend_NN toward_IN lower_JJR median_JJ S._NP aureus_NN concentrations_NNS in_IN the_DT abscesses_NNS of_IN animals_NNS that_WDT received_VBD anti-PMN_JJ serum_NN compared_VBN to_TO those_DT in_IN the_DT controls_NNS ._SENT At_IN the_DT end_NN of_IN therapy_NN on_IN day_NN 7_CD of_IN cefazolin_NN administration_NN ,_, the_DT control_NN animals_NNS had_VBD a_DT median_NN of_IN 5.55_CD log10_NN CFU_NP of_IN S._NP aureus_NN per_IN ml_NN ,_, whereas_IN the_DT animals_NNS receiving_VBG the_DT anti-PMN_NN serum_NN had_VBD 3.79_CD log10_NN CFU_NP of_IN S._NP aureus_NN per_IN ml_NN (_( P_NN =_SYM 0.04_CD by_IN the_DT Mann-Whitney_NP U_NP test_NN )_) ._SENT In_IN vitro_NP S._NP aureus_NN viability_NN after_IN PMN_JJ incubation_NN ._SENT |_SYM Following_VBG 30_CD min_NN of_IN incubation_NN with_IN rat_NN peritoneal_JJ neutrophils_NNS at_IN a_DT ratio_NN of_IN 100_CD bacteria_NNS per_IN 1_CD PMN_NN under_IN conditions_NNS conducive_JJ to_TO phagocytosis_NN ,_, the_DT S._NP aureus_NN cells_NNS showed_VBD no_DT statistically_RB significant_JJ change_NN in_IN viability_NN (_( 1.37_CD x_SYM 108_CD CFU/ml_NN in_IN the_DT control_NN tubes_NNS ,_, compared_VBN to_TO 1.30_CD x_SYM 108_CD CFU/ml_NN in_IN the_DT tubes_NNS with_IN PMN-incubated_JJ bacteria_NNS )_) ._SENT PBP_JJ expression_NN after_IN incubation_NN in_IN PMNs_NP ._SENT |_SYM After_IN the_DT in_IN vivo_JJ experiments_NNS with_IN rats_NNS demonstrated_VBD significant_JJ improvement_NN in_IN the_DT killing_NN by_IN cefazolin_NN in_IN rats_NNS with_IN neutropenia_NN ,_, we_PP assayed_VBD S._NP aureus_NN cells_NNS incubated_VBN with_IN PMNs_NP to_TO look_VB for_IN targets_NNS that_WDT interact_VBP with_IN beta-lactams_NNS ,_, specifically_RB ,_, the_DT PBPs_NP ._SENT Data_NNS from_IN six_CD separate_JJ in_IN vitro_NN PMN_NN incubations_NNS with_IN isolation_NN of_IN PBPs_NP from_IN PMN-exposed_NP and_CC control_VB S._NP aureus_NN cells_NNS are_VBP presented_VBN in_IN Fig._NN ._SENT PBP_NP 2_CD expression_NN (_( as_RB defined_VBN by_IN the_DT density_NN of_IN the_DT bound_JJ ampicillin_NN on_IN the_DT separating_VBG gel_NN )_) was_VBD decreased_VBN significantly_RB by_IN 30_CD min_NN of_IN incubation_NN of_IN the_DT S._NP aureus_NN cells_NNS with_IN activated_VBN rat_NN neutrophils_NNS ,_, and_CC the_DT level_NN of_IN PBP_NP 4_CD expression_NN increased_VBD ._SENT Although_IN the_DT number_NN of_IN internalized_VBN S._NP aureus_NN cells_NNS in_IN the_DT neutrophils_NNS were_VBD not_RB counted_VBN ,_, our_PP$ earlier_JJR studies_NNS had_VBD shown_VBN that_IN good_JJ phagocytosis_NN by_IN neutrophils_NNS occurs_VBZ as_RB early_JJ as_IN 15_CD min_NN ._SENT Biotinylated_JJ ampicillin_NN was_VBD used_VBN as_IN the_DT PBP_NP marker_NN in_IN these_DT experiments_NNS ._SENT A_DT representative_JJ image_NN density_NN graph_NN of_IN concurrently_RB run_VBN control_NN and_CC PMN-exposed_JJ S._NP aureus_NN PBPs_NP is_VBZ reproduced_VBN in_IN Fig._NN ._SENT Figure_NN also_RB shows_VBZ a_DT control_NN method_NN for_IN detection_NN of_IN biotinylated_JJ ampicillin_NN ._SENT The_DT PBP_NP was_VBD preincubated_VBN with_IN an_DT excess_NN of_IN cold_JJ ampicillin_NN before_IN biotinylated_JJ ampicillin_NN was_VBD added_VBN ,_, and_CC although_IN the_DT nonspecific_JJ band_NN at_IN the_DT top_NN shows_VBZ intense_JJ binding_NN ,_, the_DT cold_JJ ampicillin_NN blocks_NNS the_DT binding_NN of_IN biotinylated_JJ ampicillin_NN to_TO the_DT major_JJ PBPs_NNS ._SENT Figure_NN shows_NNS stained_VBD electrophoresis_NN gel_NN blots_NNS from_IN the_DT ImageQuaNT_NP program_NN (_( negatives_NNS are_VBP shown_VBN to_TO better_RBR demonstrate_VB the_DT bands_NNS )_) of_IN S._NP aureus_NN PBPs_NNS incubated_VBN with_IN PMNs_NNS and_CC controls_NNS in_IN the_DT same_JJ run_NN not_RB incubated_VBN with_IN PMNs_NP ._SENT Several_JJ procedural_JJ controls_NNS were_VBD performed_VBN with_IN these_DT in_IN vitro_NN experiments_NNS ._SENT PBPs_NNS were_VBD detected_VBN with_IN fluorescent_JJ penicillin_NN (_( Bocillin_NP FL_NP )_) and_CC digoxigenin-ampicillin_NN ,_, detected_VBN by_IN scanning_VBG of_IN a_DT fluorescent_JJ gel_NN and_CC with_IN anti-digoxigenin-alkaline_NN phosphatase_NN and_CC alkaline_JJ phosphatase_NN substrates_NNS ,_, respectively_RB ._SENT Procedural_JJ difficulties_NNS with_IN the_DT scanning_VBG and_CC printing_VBG of_IN data_NNS from_IN the_DT gels_NNS ,_, which_WDT used_VBD the_DT fluorescent_JJ penicillin_NN label_NN ,_, halted_VBD progress_NN with_IN this_DT beta-lactam_NN marker_NN ,_, although_IN the_DT loss_NN of_IN PBP_NP 2_CD with_IN incubation_NN with_IN PMNs_NP was_VBD demonstrated_VBN (_( data_NNS not_RB shown_VBN )_) ._SENT The_DT digoxigenin-beta-lactam_NN detection_NN method_NN also_RB demonstrated_VBD clear_JJ bands_NNS for_IN PBPs_NP 1_CD ,_, 2_CD ,_, 3_CD ,_, and_CC 4_CD ,_, the_DT first_JJ two_CD of_IN which_WDT could_MD be_VB blocked_VBN by_IN preincubation_NN with_IN cold_JJ ampicillin_NN ._SENT Again_RB ,_, the_DT loss_NN of_IN PBP_NP 2_CD with_IN incubation_NN with_IN PMNs_NP was_VBD demonstrated_VBN (_( data_NNS not_RB shown_VBN )_) ._SENT When_WRB neutrophils_NNS alone_RB were_VBD subjected_VBN to_TO the_DT PBP_NP isolation_NN procedure_NN with_IN a_DT beta-lactam_NN ,_, incubation_NN and_CC blotting_VBG demonstrated_VBD a_DT lack_NN of_IN important_JJ beta-lactam_NN binding_NN ._SENT This_DT suggests_VBZ that_IN the_DT densities_NNS of_IN the_DT PBPs_NP in_IN our_PP$ PMN-exposed_JJ S._NP aureus_NN isolate_NN were_VBD unlikely_JJ to_TO be_VB enhanced_VBN by_IN nonspecific_JJ beta-lactam_NN binding_VBG by_IN the_DT PMN_JJ protein_NN ._SENT FIG._NN 1_CD ._SENT |_SYM Rat_NP tissue_NN cage_NN model_NN ._SENT Rat_NN tissue_NN cage_NN model_NN ._SENT A_DT gas-sterilized_JJ table-tennis_NN ball_NN into_IN which_WDT holes_NNS were_VBD drilled_VBN was_VBD implanted_VBN by_IN sterile_JJ procedures_NNS intra-abdominally_RB in_IN large_JJ rats_NNS (_( one_CD per_IN rat_NN )_) ._SENT The_DT balls_NNS were_VBD well_RB tolerated_VBN when_WRB they_PP were_VBD infected_VBN following_VBG 5_CD weeks_NNS of_IN encapsulation_NN ._SENT The_DT model_NN was_VBD developed_VBN so_IN that_DT reagents_NNS that_WDT were_VBD unavailable_JJ for_IN the_DT rabbit_NN model_NN could_MD be_VB used_VBN ._SENT The_DT photograph_NN was_VBD made_VBN at_IN the_DT time_NN of_IN necropsy_NN of_IN a_DT rat_NN with_IN an_DT 8-day-old_JJ S._NP aureus_NN infection_NN ._SENT FIG._NN 2_CD ._SENT |_SYM Circulating_JJ blood_NN PMN_NN counts_VBZ (_( A_NP )_) and_CC abscess_VB fluid_JJ PMN_JJ counts_NNS (_( B_NP )_) during_IN treatment_NN with_IN cefazolin_NN in_IN rats_NNS infected_VBN with_IN S._NP aureus_NN Circulating_NN blood_NN PMN_NN counts_VBZ (_( A_NP )_) and_CC abscess_VB fluid_JJ PMN_JJ counts_NNS (_( B_NP )_) during_IN treatment_NN with_IN cefazolin_NN in_IN rats_NNS infected_VBN with_IN S._NP aureus_NN ._SENT Anti-PMN_JJ serum_NN of_IN rabbit_NN origin_NN (_( Accurate_NP Chemical_NP Corp._NP )_) was_VBD administered_VBN 1_CD day_NN before_IN infection_NN and_CC on_IN days_NNS 2_CD ,_, 4_CD ,_, and_CC 6_CD of_IN infection_NN (_( n_NN =_SYM 17_CD )_) ._SENT Total_JJ cell_NN counts_NNS and_CC differential_JJ counts_NNS were_VBD obtained_VBN for_IN cytospin_NN samples_NNS made_VBN with_IN abscess_NN fluid_NN sampled_VBN on_IN days_NNS 2_CD ,_, 4_CD ,_, and_CC 7_CD of_IN cefazolin_NN treatment_NN ._SENT The_DT sera_NN of_IN rats_NNS treated_VBN with_IN anti-PMN_NN serum_NN demonstrated_VBD significant_JJ drops_NNS in_IN PMN_JJ cell_NN counts_NNS on_IN all_DT days_NNS on_IN which_WDT the_DT counts_NNS were_VBD measured_VBN compared_VBN to_TO the_DT counts_NNS in_IN the_DT sera_NN of_IN rats_NNS treated_VBN with_IN control_NN serum_NN (_( n_NN =_SYM 18_CD )_) ._SENT P_NN values_NNS were_VBD determined_VBN by_IN the_DT Mann-Whitney_NP U_NP test_NN ._SENT ,_, control_NN treatment_NN ;_: ,_, treatment_NN with_IN anti-PMN_JJ serum_NN ;_: bars_NNS ,_, maximum_JJ and_CC minimum_JJ values_NNS ;_: the_DT symbols_NNS themselves_PP delineate_VBP the_DT values_NNS for_IN 25_CD to_TO 75_CD %_NN of_IN the_DT samples_NNS ;_: ,_, median_JJ values_NNS ._SENT FIG._NN 3_CD ._SENT |_SYM S._NP S._NP aureus_NN counts_NNS in_IN abscesses_NNS ._SENT Abscess_NN fluid_NN was_VBD sampled_VBN on_IN days_NNS 2_CD ,_, 4_CD ,_, and_CC 7_CD of_IN cefazolin_NN treatment_NN ._SENT The_DT bacterial_JJ count_NN at_IN day_NN 7_CD was_VBD significantly_RB lower_JJR in_IN the_DT anti-PMN-treated_JJ group_NN (_( n_NN =_SYM 17_CD )_) than_IN in_IN the_DT control_NN group_NN (_( n_NN =_SYM 18_CD )_) (_( P_NN =_SYM 0.043_CD by_IN the_DT Mann-Whitney_NP U_NP test_NN )_) ._SENT See_VB the_DT legend_NN to_TO Fig._NN for_IN definitions_NNS of_IN the_DT symbols_NNS ._SENT FIG._NN 4_CD ._SENT |_SYM Effect_NN of_IN incubation_NN with_IN PMNs_NNS on_IN the_DT S._NP aureus_NN Effect_NN of_IN incubation_NN with_IN PMNs_NNS on_IN the_DT S._NP aureus_NN PBPs_NNS ._SENT Density_NN values_NNS (_( means_NN +-_NN standard_JJ deviations_NNS for_IN six_CD runs_NNS )_) for_IN PBPs_NNS isolated_VBN from_IN bacteria_NNS incubated_VBN with_IN PMNs_NP or_CC not_RB incubated_VBN with_IN PMNs_NP were_VBD determined_VBN by_IN differential_JJ centrifugation_NN and_CC identification_NN with_IN biotinylated_JJ ampicillin_NN ._SENT PBPs_NNS were_VBD separated_VBN electrophoretically_RB ,_, blotted_VBD ,_, and_CC stained_VBN ._SENT Important_JJ PBPs_NNS were_VBD identified_VBN by_IN molecular_JJ weight_NN on_IN the_DT basis_NN of_IN two_CD standards_NNS included_VBN in_IN each_DT run_NN and_CC were_VBD quantitated_VBN with_IN imaging_NN software_NN (_( ImageQuaNT_NP )_) ._SENT After_IN exposure_NN to_TO PMNs_NP ,_, a_DT significant_JJ reduction_NN in_IN the_DT level_NN of_IN PBP_NP 2_CD expression_NN was_VBD seen_VBN ,_, as_RB defined_VBN by_IN a_DT decrease_NN in_IN gel_NN band_NN density_NN with_IN equal_JJ amounts_NNS of_IN protein_NN (_( P_NN <_SYM 0.01_CD by_IN Student_NP 's_POS t_NN test_NN )_) ._SENT The_DT levels_NNS of_IN PBP_NP 1_CD and_CC PBP_NP 3_CD expression_NN were_VBD not_RB significantly_RB changed_VBN ._SENT The_DT level_NN of_IN PBP_NP 4_CD expression_NN showed_VBD a_DT significant_JJ increase_NN in_IN the_DT biotinylated_JJ ampicillin_NN series_NN that_WDT was_VBD not_RB seen_VBN by_IN the_DT methods_NNS that_WDT used_VBD fluorescent_JJ penicillin_NN ._SENT FIG._NN 5_CD ._SENT |_SYM ImageQuaNT_NP scans_NNS of_IN S._NP aureus_NN ImageQuaNT_NN scans_VBZ of_IN S._NP aureus_NN PBPs_NP (_( the_DT numbers_NNS above_IN each_DT peak_NN )_) ._SENT A_DT representative_NN run_VBN of_IN viable_JJ S._NP aureus_NN cells_NNS incubated_VBN or_CC not_RB incubated_VBN with_IN viable_JJ neutrophils_NNS for_IN 30_CD min_NN is_VBZ shown_VBN ._SENT Cell_NN wall_NN proteins_NNS were_VBD subsequently_RB isolated_VBN ;_: incubated_VBN with_IN biotinylated_JJ ampicillin_NN ;_: and_CC separated_VBN on_IN a_DT gel_NN ,_, blotted_VBD ,_, and_CC stained_VBN ._SENT The_DT third_JJ scan_NN at_IN the_DT bottom_NN is_VBZ a_DT methods_NNS control_NN :_: S._NP aureus_NN membrane_NN proteins_NNS were_VBD incubated_VBN with_IN unlabeled_JJ ampicillin_NN in_IN excess_NN for_IN 30_CD min_NN at_IN 37C_JJ before_IN incubation_NN with_IN biotinylated_JJ ampicillin_NN for_IN 30_CD min_NN at_IN 37C_JJ ,_, followed_VBN by_IN performance_NN of_IN the_DT standard_JJ run_NN ._SENT FIG._NN 6_CD ._SENT |_SYM Photo_NP from_IN the_DT density_NN program_NN of_IN S._NP Photo_NP from_IN the_DT density_NN program_NN of_IN S._NP aureus_NN PBPs_NNS incubated_VBN without_IN or_CC with_IN neutrophils_NNS before_IN cell_NN wall_NN isolation_NN and_CC electrophoresis_NN ._SENT The_DT cell_NN wall_NN proteins_NNS were_VBD subsequently_RB isolated_VBN ,_, incubated_VBN with_IN biotinylated_JJ ampicillin_NN ,_, and_CC separated_VBD electrophoretically_RB and_CC were_VBD blotted_VBN and_CC stained_VBN with_IN streptavidin-alkaline_NN phosphatase_NN and_CC then_RB the_DT BCIP-NBT_NN substrate_NN ._SENT The_DT photo_NN is_VBZ from_IN the_DT software_NN program_NN used_VBN to_TO determine_VB band_NN density_NN ._SENT PBPs_NNS are_VBP indicated_VBN to_TO the_DT right_NN of_IN the_DT gel_NN ._SENT The_DT experiments_NNS described_VBD here_RB have_VB demonstrated_VBN that_IN in_IN vivo_JJ depletion_NN of_IN neutrophils_NNS allows_VBZ more_RBR efficacious_JJ killing_NN of_IN S._NP aureus_NN by_IN a_DT beta-lactam_NN in_IN a_DT host_NN 's_POS established_JJ infection_NN and_CC are_VBP novel_JJ in_IN terms_NNS of_IN the_DT model_NN used_VBD and_CC the_DT level_NN of_IN quantification_NN ._SENT Others_NNS have_VBP previously_RB considered_VBN our_PP$ suggestion_NN regarding_VBG the_DT mechanism_NN of_IN the_DT changes_NNS in_IN bacterial_JJ cell_NN wall_NN enzymes_NNS during_IN phagocytosis_NN by_IN PMNs_NP ._SENT Rakita_NP et_FW al._FW have_VBP previously_RB suggested_VBN that_IN neutrophils_NNS may_MD inactivate_VB the_DT PBPs_NNS of_IN bacteria_NNS ._SENT They_PP found_VBD that_IN the_DT levels_NNS of_IN seven_CD E._NP coli_NNS PBPs_NNS declined_VBD over_IN 30_CD min_NN of_IN incubation_NN with_IN neutrophils_NNS and_CC that_IN the_DT decline_NN in_IN the_DT PBP_NP levels_NNS correlated_VBN with_IN a_DT loss_NN of_IN viability_NN in_IN E._NP coli_NNS ._SENT Vriesema_NP et_FW al._FW showed_VBD the_DT potential_NN for_IN genetic_JJ changes_NNS in_IN S._NP aureus_NN internalized_VBN in_IN cells_NNS ._SENT Using_VBG a_DT transposon-based_JJ expression_NN library_NN of_IN S._NP aureus_NN ,_, they_PP reported_VBD that_IN bacterial_JJ genes_NNS were_VBD upregulated_VBN by_IN exposure_NN to_TO endothelial_JJ cells_NNS ;_: among_IN these_DT were_VBD genes_NNS encoding_VBG enzymes_NNS leading_VBG to_TO cell_NN wall_NN biosynthesis_NN ._SENT Our_PP$ results_NNS with_IN S._NP aureus_NN furnish_VB no_DT genetic_JJ data_NNS but_CC demonstrate_VB the_DT decrease_NN in_IN the_DT density_NN of_IN PBP_NP 2_CD after_IN incubation_NN with_IN PMNs_NP ._SENT The_DT density_NN of_IN a_DT peak_NN corresponding_JJ to_TO PBP_NP 4_CD increased_VBD with_IN incubation_NN with_IN PMNs_NP ._SENT However_RB ,_, control_NN experiments_NNS with_IN another_DT beta-lactam_NN label_NN suggested_VBD that_IN the_DT increased_VBN density_NN of_IN a_DT peak_NN corresponding_JJ to_TO PBP_NP 4_CD might_MD have_VB occurred_VBN only_RB with_IN biotinylated_JJ ampicillin_NN in_IN our_PP$ assays_NNS ,_, so_RB the_DT change_NN in_IN the_DT level_NN of_IN expression_NN of_IN that_WDT PBP_NP remains_VBZ undefined_JJ ._SENT The_DT change_NN in_IN the_DT level_NN of_IN PBP_NP 2_CD expression_NN was_VBD not_RB associated_VBN with_IN an_DT identifiable_JJ loss_NN in_IN S._NP aureus_NN viability_NN ,_, as_RB determined_VBN by_IN dilution_NN plating_NN (_( in_IN ice_NN water_NN )_) of_IN the_DT PMN-exposed_JJ and_CC control_NN bacteria_NNS at_IN the_DT end_NN of_IN the_DT incubation_NN ._SENT There_EX is_VBZ some_DT evidence_NN that_IN alterations_NNS in_IN PBP_NP 2_CD could_MD affect_VB the_DT activity_NN of_IN cefazolin_NN ._SENT The_DT 50_CD %_NN inhibitory_JJ doses_NNS of_IN cefazolin_NN for_IN PBP_NP 2_CD and_CC PBP_NP 4_CD from_IN susceptible_JJ staphylococci_NNS were_VBD 0.078_CD and_CC >30_JJ mug/ml_NN ,_, respectively_RB ._SENT By_IN using_VBG those_DT published_VBN values_NNS ,_, a_DT decrease_NN in_IN the_DT level_NN of_IN PBP_NP 2_CD expression_NN may_MD adversely_RB affect_VB the_DT activity_NN of_IN cefazolin_NN ._SENT We_PP considered_VBD the_DT additional_JJ possibility_NN that_IN the_DT PBP_NP modifications_NNS that_IN we_PP saw_VBD could_MD be_VB artifacts_NNS ._SENT Since_IN PBPs_NP are_VBP enzymes_NNS ,_, they_PP are_VBP heat_NN and_CC pH_NN sensitive_JJ ,_, and_CC perhaps_RB these_DT factors_NNS in_IN vitro_NN changed_VBN certain_JJ PBPs_NNS rather_RB than_IN the_DT neutrophils_NNS ._SENT We_PP consider_VBP this_DT unlikely_JJ ,_, because_IN buffered_VBN HBSS_NP was_VBD added_VBN to_TO both_DT PMN_NN and_CC control_NN bacteria_NNS ,_, and_CC PMN-treated_JJ and_CC control_NN bacteria_NNS were_VBD incubated_VBN in_IN an_DT identical_JJ fashion_NN ._SENT We_PP also_RB considered_VBD the_DT possibility_NN that_IN our_PP$ cell_NN wall_NN preparations_NNS included_VBD neutrophilic_JJ protein_NN only_RB in_IN the_DT preparations_NNS consisting_VBG of_IN exposed_JJ S._NP aureus_NN cells_NNS and_CC not_RB in_IN the_DT control_NN preparations_NNS and_CC that_IN such_JJ proteins_NNS produce_VBP nonspecific_JJ binding_NN that_WDT augments_VBZ the_DT intensities_NNS of_IN some_DT of_IN the_DT PBPs_NP ._SENT We_PP found_VBD it_PP difficult_JJ to_TO control_VB for_IN the_DT phagocytosis_NN of_IN S._NP aureus_NN by_IN the_DT added_JJ neutrophils_NNS ,_, as_IN it_PP was_VBD very_RB rapid_JJ ._SENT Subsequently_RB ,_, we_PP tested_VBD the_DT entire_JJ S._NP aureus_NN cell_NN wall_NN isolation_NN method_NN using_VBG only_RB fresh_JJ neutrophils_NNS (_( no_DT bacteria_NNS )_) ._SENT The_DT PMN_JJ protein_NN produced_VBD no_DT PBP_NP bands_NNS when_WRB it_PP was_VBD incubated_VBN with_IN a_DT labeled_VBN beta-lactam_NN and_CC electrophoretically_RB separated_VBN ,_, blotted_VBN ,_, and_CC stained_VBN ._SENT Furthermore_RB ,_, if_IN the_DT PMN_JJ protein_NN in_IN conjunction_NN with_IN S._NP aureus_NN PBPs_NP binds_VBZ to_TO beta-lactam_NN labels_NNS nonspecifically_RB ,_, the_DT observed_JJ decrease_NN in_IN the_DT level_NN of_IN PBP_NP 2_CD expression_NN should_MD not_RB have_VB occurred_VBN with_IN the_DT S._NP aureus_NN cells_NNS incubated_VBN with_IN PMNs_NP ._SENT We_PP used_VBD the_DT method_NN of_IN Dargis_NP and_CC Malouin_NP for_IN biotinylation_NN of_IN ampicillin_NN for_IN detection_NN of_IN PBPs_NP ._SENT The_DT rapid_JJ results_NNS (_( compared_VBN to_TO the_DT time_NN to_TO retrieval_NN of_IN results_NNS by_IN use_NN of_IN isotope_NN labels_NNS )_) are_VBP a_DT great_JJ benefit_NN from_IN the_DT use_NN of_IN colorimetric_JJ labels_NNS ._SENT A_DT disadvantage_NN ,_, as_RB reported_VBN previously_RB (_( 8_CD )_) ,_, are_VBP the_DT occasional_JJ nonspecific_JJ bands_NNS which_WDT are_VBP not_RB consistent_JJ with_IN the_DT molecular_JJ weights_NNS of_IN S._NP aureus_NN PBP_NP 1_CD ,_, 2_CD ,_, 3_CD ,_, or_CC 4_CD ._SENT As_IN controls_NNS for_IN the_DT possible_JJ nonspecific_JJ binding_NN of_IN endogenous_JJ bacterial_JJ streptavidin_NN to_TO the_DT biotinylated_JJ label_NN ,_, we_PP demonstrated_VBD that_IN binding_VBG of_IN the_DT biotinylated_JJ ampicillin_NN label_NN (_( to_TO high-molecular-weight_JJ PBPs_NNS )_) could_MD be_VB blocked_VBN by_IN preincubation_NN with_IN cold_JJ ampicillin_NN ._SENT We_PP subsequently_RB successfully_RB used_VBN other_JJ labels_NNS that_WDT did_VBD not_RB involve_VB biotin_NN to_TO detect_VB S._NP aureus_NN PBPs_NNS ._SENT A_DT few_JJ additional_JJ beta-lactam_NN binding_VBG protein_NN bands_NNS ,_, in_IN addition_NN to_TO the_DT PBPs_NP ,_, were_VBD occasionally_RB seen_VBN even_RB with_IN the_DT fluorescent_JJ penicillin_NN label_NN ._SENT It_PP is_VBZ possible_JJ that_IN these_DT bands_NNS could_MD be_VB isolation_NN artifacts_NNS :_: breakdown_NN products_NNS of_IN the_DT cell_NN walls_NNS of_IN S._NP aureus_NN with_IN proteins_NNS with_IN low-affinity_NN binding_NN that_WDT are_VBP visible_JJ by_IN the_DT brief_JJ (_( minutes_NNS )_) development_NN procedures_NNS used_VBN in_IN this_DT study_NN but_CC not_RB expressed_VBN over_IN the_DT long_JJ development_NN time_NN (_( weeks_NNS )_) required_VBN for_IN isotope_NN labels_NNS ._SENT Further_JJR work_NN on_IN PBP_NP labeling_VBG techniques_NNS should_MD be_VB performed_VBN ,_, but_CC such_JJ work_NN was_VBD beyond_IN the_DT scope_NN of_IN this_DT study_NN ._SENT In_IN previous_JJ experiments_NNS with_IN a_DT rabbit_NN S._NP aureus_NN tissue_NN cage_NN abscess_NN model_NN similar_JJ to_TO the_DT model_NN used_VBN in_IN the_DT present_JJ study_NN ,_, we_PP have_VBP found_VBN that_IN circulating_VBG neutrophils_NNS from_IN hosts_NNS with_IN 14-day-old_JJ abscesses_NNS had_VBD diminished_VBN bactericidal_JJ capacities_NNS and_CC a_DT diminished_JJ ability_NN to_TO generate_VB superoxide_NN compared_VBN to_TO those_DT for_IN 1-day-old_JJ infections_NNS ._SENT Phagocytosis_NN was_VBD relatively_RB well_RB preserved_VBN ._SENT Additionally_RB ,_, in_IN in_IN vitro_NN assays_NNS ,_, abscess_NN fluid_NN further_RBR inhibited_VBD the_DT bactericidal_JJ capacity_NN of_IN normal_JJ neutrophils_NNS ._SENT In_IN a_DT report_NN of_IN a_DT study_NN by_IN Gresham_NP et_FW al._FW ,_, who_WP used_VBD a_DT staphylococcal_JJ peritonitis_NN mouse_NN model_NN ,_, the_DT survival_NN of_IN S._NP aureus_NN within_IN neutrophils_NNS was_VBD vital_JJ to_TO the_DT pathogenesis_NN of_IN the_DT infection_NN ,_, and_CC intracellular_JJ survival_NN was_VBD found_VBN to_TO be_VB regulated_VBN by_IN sar_NN ,_, a_DT global_JJ regulator_NN that_WDT influences_VBZ the_DT intracellular_JJ locale_NN of_IN phagocytized_JJ bacteria_NNS ._SENT Limiting_VBG the_DT influx_NN of_IN neutrophils_NNS enhanced_JJ survival_NN and_CC reduced_VBD the_DT bacterial_JJ burden_NN after_IN 24_CD h_NN of_IN infection_NN by_IN decreasing_VBG the_DT numbers_NNS of_IN intracellular_JJ bacteria_NNS ._SENT There_EX are_VBP numerous_JJ reports_NNS of_IN studies_NNS that_WDT have_VBP evaluated_VBN the_DT intracellular_JJ concentrations_NNS and_CC activities_NNS of_IN antimicrobials_NNS ._SENT Ratios_NNS of_IN concentrations_NNS in_IN PMNs_NNS to_TO extracellular_JJ concentrations_NNS of_IN up_IN to_TO 0.60_CD have_VBP been_VBN reported_VBN for_IN beta-lactams_NNS ,_, and_CC these_DT would_MD likely_RB provide_VB intracellular_JJ concentrations_NNS well_RB above_IN the_DT minimal_JJ bactericidal_JJ concentration_NN for_IN typical_JJ staphylococci_NNS ._SENT Hand_NN and_CC King-Thompson_NP reported_VBD an_DT intracellular_JJ concentration-to-extracellular_JJ concentration_NN ratio_NN of_IN 0.45_CD for_IN neutrophils_NNS that_WDT had_VBD phagocytized_VBN S._NP aureus_NN but_CC found_VBD that_IN the_DT intracellular_JJ penicillin_NN did_VBD not_RB enhance_VB the_DT killing_NN of_IN phagocytized_JJ S._NP aureus_NN ._SENT In_IN their_PP$ study_NN of_IN penicillin_NN ,_, clindamycin_NN ,_, rifampin_NN ,_, gentamicin_NN ,_, and_CC erythromycin_NN ,_, there_EX was_VBD a_DT poor_JJ correlation_NN between_IN the_DT intracellular_JJ penetration_NN of_IN antimicrobials_NNS and_CC intracellular_JJ killing_VBG activity_NN ._SENT These_DT data_NNS suggest_VBP that_IN the_DT poor_JJ activities_NNS of_IN beta-lactams_NNS against_IN intra-PMN_JJ staphylococci_NNS may_MD not_RB be_VB secondary_JJ to_TO the_DT presence_NN of_IN an_DT inadequate_JJ concentration_NN of_IN drug_NN but_CC is_VBZ due_JJ to_TO inadequate_JJ activity_NN in_IN the_DT intracellular_JJ milieu_NN ._SENT We_PP suggest_VBP that_IN our_PP$ measurements_NNS for_IN S._NP aureus-infected_JJ ,_, neutropenic_JJ rats_NNS described_VBN in_IN this_DT report_NN have_VBP demonstrated_VBN that_IN cefazolin_NN kills_VBZ S._NP aureus_NN cells_NNS in_IN animals_NNS with_IN chronic_JJ infection_NN more_RBR efficiently_RB when_WRB neutrophils_NNS are_VBP depleted_VBN ._SENT We_PP postulate_VBP that_IN the_DT inactivation_NN or_CC diminished_JJ expression_NN of_IN PBP_NP 2_CD after_IN incubation_NN with_IN PMNs_NP ex_NN vivo_RB describes_VBZ what_WP is_VBZ happening_VBG in_IN our_PP$ animal_JJ model_NN and_CC results_NNS in_IN (_( i_NP )_) good_JJ phagocytosis_NN by_IN PMNs_NP ,_, (_( ii_NNS )_) a_DT poor_JJ bactericidal_JJ capacity_NN of_IN PMNs_NP ,_, and_CC (_( iii_NNS )_) viable_JJ but_CC changed_JJ S._NP aureus_NN cells_NNS with_IN diminished_JJ targets_NNS for_IN the_DT cefazolin_NN ._SENT Our_PP$ hypothesis_NN is_VBZ similar_JJ to_TO that_DT of_IN Stevens_NP et_FW al._FW ,_, who_WP postulated_VBD that_IN the_DT diminished_JJ expression_NN of_IN PBPs_NNS by_IN stationary-phase_NN group_NN A_DT streptococci_NNS might_MD explain_VB the_DT diminished_JJ efficacies_NNS of_IN beta-lact_NN 